Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating and monitoring the conduct of the Board of Directors of Gerber Scientific, Inc. (“Gerber” or the “Company”) (NYSE: GRB) in relation to the sale of the Company to Vector Capital Corp. for about $282 million. The proposed transaction offers Gerber’s shareholders $11.00 per share in cash. The proposed cash consideration represents an approximate 24% premium over Gerber’s average 30-day closing price, though Gerber’s stock value increased by 45% over the past 12 months.
Request more information now by clicking here:
Whether Gerber’s Board of Directors breached their fiduciary duties to Gerber’s stockholders by failing to conduct an adequate and fair sales process to sell the Company prior to agreeing to this proposed transaction, whether the proposed transaction undervalues Gerber’s shares and by how much this proposed transaction undervalues the Company to the detriment of Gerber’s shareholders are the key focus of this investigation.
Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, through all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm’s clients.
If you own common stock in Gerber and wish to obtain additional information, please visit us at
or contact Juan E. Monteverde, Esq. either via e-mail at
or by telephone at (877) 247-4292 or (212) 983-9330.
Attorney Advertising. (C) 2011 Faruqi & Faruqi, LLP. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (
). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We are happy to discuss your particular case.